Virendra Kumar
51Patents
18h-index
36Co-inventors
80Inventor score
Filing activity: Mar 22, 1989 → Oct 5, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5488055A | Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof | Human Necessities | 56 | Expired |
| US5646151A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 55 | Expired |
| US5614530A | Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof | Human Necessities | 52 | Expired |
| US5688955A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 40 | Expired |
| US5569655A | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof | Chemistry; Metallurgy | 34 | Expired |
| US6486165B2 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 32 | Expired |
| US5869521A | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith | Human Necessities | 30 | Expired |
| US5667773A | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith | Human Necessities | 29 | Expired |
| US5763445A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5760023A | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith | Human Necessities | 29 | Expired |
| US5068234A | 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles | Chemistry; Metallurgy | 28 | Expired |
| US5981513A | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5292736A | Morpholinoalkylindenes as antiglaucoma agents | Human Necessities | 24 | Expired |
| US5744458A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 24 | Expired |
| US6303611A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 23 | Expired |
| US6057323A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 21 | Expired |
| US6054445A | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritis therewith | Chemistry; Metallurgy | 20 | Expired |
| US6156769A | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith | Human Necessities | 20 | Expired |
| US6492351B1 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 17 | Expired |
| US6476063B2 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith | Chemistry; Metallurgy | 17 | Expired |
| US5888494A | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith | Human Necessities | 16 | Expired |
| US5488062A | 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof | Human Necessities | 15 | Expired |
| US5455248A | Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof | Chemistry; Metallurgy | 14 | Expired |
| US6048860A | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith | Human Necessities | 12 | Expired |
| US5945443A | Kappa agonist compounds and pharmaceutical formulations thereof | Chemistry; Metallurgy | 11 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.